Man Au Yeung

Imperial College Healthcare NHS Trust

Papers

1

Total Citations

7

H-Index

1

About

Dr. Man Au Yeung is a urological oncologist whose research focuses on improving risk stratification and treatment outcomes for prostate cancer, particularly in high-risk patient populations. His key contributions center on refining preoperative staging methods to better predict disease progression and guide surgical decision-making. In his influential 2021 study, "Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer?" (7 citations), Dr. Au Yeung challenged conventional staging paradigms by investigating whether tumor volume—a metric often overlooked in favor of PSA levels, ISUP grade group, and multiparametric MRI—could serve as an independent prognostic factor. This work highlights his commitment to integrating quantitative pathological measures into clinical practice, potentially enhancing the precision of radical prostatectomy outcomes. His research bridges the gap between traditional clinical parameters and emerging imaging-based assessments, offering a more nuanced understanding of tumor biology. Dr. Au Yeung’s findings have implications for tailoring postoperative surveillance and adjuvant therapies, underscoring his role in advancing evidence-based urological oncology. His work continues to inspire further investigation into volumetric analysis as a tool for personalizing prostate cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer?
7 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Imperial College Healthcare NHS Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 21 days ago